Filing Flows › Whitehawk Therapeutics (WHWK) › Q1 2025 › vs Q4 2024
Whitehawk Therapeutics (WHWK) Q1 2025 vs Q4 2024 (quarter over quarter)
Whitehawk Therapeutics's revenue fell $94K (-1%) from $7.2M in Q4 2024 to $7.1M in Q1 2025.
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $7.1M | $7.2M | −$94K | -1% |
| Other income, net | $88.2M | $676K | $87.6M | 131× |
| Costs & expenses | $95.4M | $26.2M | $69.2M | +264% |
| Operating costs | $22.4M | $26.2M | −$3.8M | -15% |
| Net earnings | $73.0M | −$18.3M | $91.3M | — |
| Cost of revenue | $760K | $790K | −$30K | -4% |
| Research & development | $8.8M | $14.3M | −$5.6M | -39% |
| SG&A | $12.8M | $11.1M | $1.8M | +16% |
| Operating cash sources | $86.6M | −$1.3M | $87.9M | — |
| Depreciation | $57K | $54K | $3K | +6% |
| Share-based compensation | $1.7M | $1.9M | −$174K | -9% |
| Cash used in operations | $11.9M | $15.1M | −$3.2M | -21% |
| Working capital & other | $86.6M | −$1.3M | $87.9M | — |
Questions
How much did Whitehawk Therapeutics's revenue grow quarter over quarter in Q1 2025?
Whitehawk Therapeutics's revenue fell $94K (-1%) from $7.2M in Q4 2024 to $7.1M in Q1 2025.